"So the 6 months late (trial ended april 2019 instead of nov 2018) was because of funding and not because treated group was doing well...?"

At the December 2017 AGM, Resverlogix was predicting top-line data by Q4 2018. Top-line is now expected by end of Q3 2019. So the delay for top-line data relative to December 2017 expectations is 3-4 quarters (9-12 months) depending on where you put the quarter cut-offs. The April 2019 date was the onset of the final non-adjudicated event and start of the last study visits.

BearDownAZ